Skip to content
Marathon Money

Free Investing Classes

Live sessions where I teach how I invest, how I trade, and what I'm learning from the CEOs I interview. No catch — just join.

Sign Up Free →
  • Real trades. Real reasoning.
  • CEO interviews you can't get anywhere else.
  • 100% free. Always.
  • Fri. Jul 24th, 2026
  • Home
  • Inside the Ticker
    • Marathon Money Free Investment Classes
    • The Ticker Room
      • Publicly Traded CEO Interviews, Stock Market Analysis & Investor Insights
      • Text Alerts (Members Only)
    • Annual Letter | Marathon Money
  • Marathon Money Newsroom
  • Log In
  • MooMoo Partnership
  • Join MM +
  • Categories
    • Marathon Money Podcast
    • MM+
    • Manage Subscriptions
    • MM+ Portfolio
  • Contact Us
FREE
Inside the Ticker Marathon Money Newsroom Marathon Money Podcast MM+

60 DEGREES PHARMACEUTICALS  |  NASDAQ: SXTP Dr. Geoffrey Dow, founder and CEO of 60 Degrees Pharmaceuticals, for an exclusive Marathon Money interview

March 25, 2026 0

60 Degrees Pharmaceuticals (NASDAQ: SXTP) might be one of the most overlooked micro-cap opportunities in the biotech space right now. We sat down with CEO Dr. Geoffrey Dow to uncover…

Read More

Inside the Ticker Marathon Money Podcast

Cosa Resources COSAF Uranium Discovery Potential and 2026 Outlook

March 17, 2026 0

Marathon Money recently sat down with Keith Bodnarchuk, CEO of Cosa Resources Corp, along with Cole from the company’s leadership team to discuss their exploration plans, the uranium market, and…

Read More

Inside the Ticker The Ticker Room

60 Degrees Pharmaceuticals (NASDAQ: SXTP)

March 9, 2026 0

Micro-Float Biotech With Upcoming Catalysts and CEO Interview on the Horizon Company Snapshot Item Details Company 60 Degrees Pharmaceuticals Inc Ticker NASDAQ: SXTP Sector Biotechnology / Infectious Disease Primary Product…

Read More

Inside the Ticker Marathon Money Podcast

High Roller Technologies Charts 2026 Growth Strategy with Prediction Markets, New Capital and Expanded Marketing

February 26, 2026 0

Lead Summary (Marathon Money Style)High Roller Technologies Inc (NYSEAMERICAN: ROLR) updated shareholders and the market on a series of strategic initiatives aimed at expanding its revenue base beyond online casino…

Read More

Inside the Ticker Marathon Money Newsroom Marathon Money Podcast

Virtuix (VTIX) CEO Interview: AI Battlefield Simulation, Defense Growth Strategy and Future Revenue Plan

February 11, 2026 0

Virtuix Holdings (NASDAQ: VTIX) returns to Marathon Money following its IPO to discuss its expanding defense opportunity and the rollout of its AI-powered Virtual Terrain Walk system. In this interview,…

Read More

Inside the Ticker Marathon Money Newsroom MM+

Investment Thesis: Numeraire (NMR)

February 6, 2026 0

By Kenny Colin, Marathon Money Executive Summary Numeraire, ticker NMR, is the cryptocurrency that powers Numerai, a hedge fund built on crowdsourced machine learning. Independent data scientists from around the…

Read More

Inside the Ticker Marathon Money Newsroom Marathon Money Podcast MM+

Virtuix (VTIX) CEO Interview | Nasdaq Direct Listing January 27 | Omni VR Treadmill IPO Breakdown

January 27, 2026 0

In this exclusive interview, we sit down with Jan Goetgeluk, Founder and CEO of Virtuix Holdings, ahead of the company’s upcoming Nasdaq direct listing under the ticker VTIX, expected to…

Read More

Inside the Ticker Marathon Money Newsroom Money Sprints

Undervalued Stocks, Proven CEOs, and Asymmetric Market Opportunities Investors Are Watching in 2026

January 26, 2026 0

Markets do not move in straight lines. Capital flows first to certainty, then to opportunity, and only later to stories. The companies outlined below sit at different points on that…

Read More

Inside the Ticker Marathon Money Newsroom Marathon Money Podcast

SAGMF | CEO Returns After Stock Rises From $0.28 to $0.70 | What Changed Since October

January 20, 2026 0

This was our second time sitting down with the CEO on Inside the Ticker, and I think the timing tells the story better than anything else. When he first came…

Read More

Inside the Ticker Marathon Money Newsroom The Ticker Room

Marathon Money Option for 2026 #2

January 8, 2026 0

Marathon Money Option #2 for 2026 is live. Defined-risk downside setup. Full breakdown in members area.

Read More

« Previous Page — Next Page »

You missed

Inside the Ticker Marathon Money Newsroom Marathon Money Podcast MM+

UMAC Trade Breakdown & CEO Interview Analysis

July 13, 2026 0
Inside the Ticker Marathon Money Newsroom Marathon Money Podcast

MEDH Deep Dive

June 30, 2026 1
Marathon Money Newsroom MM+ The Ticker Room

I Bought Puts on SpaceX.Yeah, I Know.

June 22, 2026 0
Annual Letter | Marathon Money Inside the Ticker Marathon Money Podcast

Virtuix Holdings NASDAQ: VTIX

May 27, 2026 0

Marathon Money +

MM+

© Copyright 2025 Marathon Money. All Rights Reserved. by Marathon Money

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT